Skip to Content

Orion Oyj ADR ORINY

Morningstar Rating
$18.00 −0.70 (3.74%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ORINY is trading at a 5% premium.
Price
$17.97
Fair Value
$88.56
Uncertainty
High
1-Star Price
$19.90
5-Star Price
$14.35
Economic Moat
Hclrzw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ORINY is a good fit for your portfolio.

Trading Information

Previous Close Price
$18.70
Day Range
$18.0018.00
52-Week Range
$18.0026.26
Bid/Ask
$17.90 / $19.24
Market Cap
$5.06 Bil
Volume/Avg
330 / 438

Key Statistics

Price/Earnings (Normalized)
23.45
Price/Sales
3.93
Dividend Yield (Trailing)
2.44%
Dividend Yield (Forward)
2.44%
Total Yield
2.44%

Company Profile

Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries, North America and other countries.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Mid Core
Total Number of Employees
3,632

Comparables

Valuation

Metric
ORINY
OKDAV
BEACONPHAR
Price/Earnings (Normalized)
23.4569.3671.72
Price/Book Value
5.141.187.24
Price/Sales
3.930.134.87
Price/Cash Flow
17.718.83
Price/Earnings
ORINY
OKDAV
BEACONPHAR

Financial Strength

Metric
ORINY
OKDAV
BEACONPHAR
Quick Ratio
1.730.560.39
Current Ratio
3.120.791.22
Interest Coverage
52.73−2.661.76
Quick Ratio
ORINY
OKDAV
BEACONPHAR

Profitability

Metric
ORINY
OKDAV
BEACONPHAR
Return on Assets (Normalized)
15.20%−0.37%4.32%
Return on Equity (Normalized)
25.42%−1.79%10.35%
Return on Invested Capital (Normalized)
20.52%−0.22%9.14%
Return on Assets
ORINY
OKDAV
BEACONPHAR
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
LLY
Eli Lilly and CoQsxglmstWtv$739.9 Bil
JNJ
Johnson & JohnsonYltnqdntpTsf$380.6 Bil
MRK
Merck & Co IncXgshknhtJxf$333.7 Bil
ABBV
AbbVie IncFsyktpcyGvxt$319.3 Bil
AZN
AstraZeneca PLC ADRHghbvqysyYzzj$210.3 Bil
RHHBY
Roche Holding AG ADRPsptkzxlhSqjr$201.6 Bil
NVS
Novartis AG ADRJywqhbmlYjyd$196.0 Bil
PFE
Pfizer IncRmqtjnxtHyyx$157.3 Bil
AMGN
Amgen IncLfjtvcvjsDfc$153.4 Bil
SNY
Sanofi SA ADRLhdqdtpwQstj$124.1 Bil

Sponsor Center